IR-Med Statistics
Total Valuation
IR-Med has a market cap or net worth of 1.17 million. The enterprise value is 1.36 million.
| Market Cap | 1.17M |
| Enterprise Value | 1.36M |
Important Dates
The last earnings date was Wednesday, August 13, 2025.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IR-Med has 77.24 million shares outstanding. The number of shares has increased by 2.34% in one year.
| Current Share Class | 77.24M |
| Shares Outstanding | 77.24M |
| Shares Change (YoY) | +2.34% |
| Shares Change (QoQ) | +3.50% |
| Owned by Insiders (%) | 56.99% |
| Owned by Institutions (%) | n/a |
| Float | 29.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -1.87 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.58 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.12
| Current Ratio | 0.12 |
| Quick Ratio | 0.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.57 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -172.32% |
| Return on Invested Capital (ROIC) | -1,262.07% |
| Return on Capital Employed (ROCE) | 244.41% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -587,500 |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.09% in the last 52 weeks. The beta is 1.88, so IR-Med's price volatility has been higher than the market average.
| Beta (5Y) | 1.88 |
| 52-Week Price Change | -97.09% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.69 |
| Relative Strength Index (RSI) | 36.11 |
| Average Volume (20 Days) | 231,952 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.00 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.46M |
| Pretax Income | -2.35M |
| Net Income | -2.35M |
| EBITDA | -1.45M |
| EBIT | -1.46M |
| Earnings Per Share (EPS) | -0.03 |
Balance Sheet
The company has 63,000 in cash and 250,000 in debt, giving a net cash position of -187,000 or -0.00 per share.
| Cash & Cash Equivalents | 63,000 |
| Total Debt | 250,000 |
| Net Cash | -187,000 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -625,000 |
| Book Value Per Share | -0.01 |
| Working Capital | -684,000 |
Cash Flow
| Operating Cash Flow | -837,000 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IR-Med does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.34% |
| Shareholder Yield | n/a |
| Earnings Yield | -200.89% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 26, 2020. It was a reverse split with a ratio of 0.001.
| Last Split Date | Feb 26, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.001 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |